Treatment of non-metastatic castration-resistant prostate cancer: focus on apalutamide
Anita Gul,1 Jorge A Garcia,1 Pedro C Barata21Department of Hematology/Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA; 2Tulane University, New Orleans, LA, USAAbstract: Androgen deprivation therapy (ADT) is an important component of systemic therapy in advanced prosta...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-08-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/treatment-of-non-metastatic-castration-resistant-prostate-cancer-focus-peer-reviewed-article-CMAR |